🧪 Composition

• Active Ingredient: Eltrombopag Olamine (equivalent to Eltrombopag 25 mg)
• Dosage Form: Oral Tablet
• Strength: 25 mg

✅ Uses

• Helps treat chronic immune thrombocytopenia (ITP) in eligible patients.
• Supports platelet production in individuals with severe aplastic anemia when appropriate.
• May be prescribed for selected patients with thrombocytopenia associated with chronic hepatitis C to help maintain platelet levels during treatment, based on the physician’s assessment.

💉 Dosage

The dosage of Eltrombopag 25 mg should always be determined by a healthcare professional. The dose may vary depending on the patient’s condition, platelet count, age, and response to therapy. Regular blood tests are recommended to monitor platelet levels and adjust treatment when necessary.

⚠️ Precautions

• Use only under medical supervision.
• Regular monitoring of platelet count and liver function may be required.
• Inform your doctor about all current medications and existing medical conditions before starting treatment.
• Do not change or discontinue the medication without consulting your healthcare provider.

📦 Storage

Store below 30°C in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of the reach of children.

⭐ Conclusion

Eltrombopag 25 mg is an effective treatment option for selected patients with low platelet counts caused by specific medical conditions. When used according to medical advice and with regular monitoring, it can help improve platelet production and support better treatment outcomes. Always follow your healthcare professional’s recommendations for safe and effective use.